CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to identify the molecular targets of new antimalarial compounds using a chemical proteomic approach. By screening promising compounds against specific enzyme families in malaria-infected cells, the project seeks to validate new targets for drug development, addressing the urgent need for effective mal…
Malaria is one of the most devastating infectious diseases affecting half of the world population and killing close to a million people every year.
Widespread resistance of the malaria parasite to most front-line drugs and the rapid emergence of resistance against new therapies have made the validation of novel pharmaceutical targets and the identification of potent pharmacophores extremely urgent.
In an effort to synergize basic research with malarial drug development the pharmaceutical industr…
THE FRANCIS CRICK INSTITUTE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, LONDON
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
